Stockscreener 앱 받기
2.71
3.21%
-0.09
시간 외 거래:
2.77
0.06
+2.21%
전일 마감가:
$2.80
열려 있는:
$2.76
하루 거래량:
806.29K
Relative Volume:
1.46
시가총액:
$341.49M
수익:
$4.75M
순이익/손실:
$-7.83M
주가수익비율:
12.45
EPS:
0.2177
순현금흐름:
$-7.24M
1주 성능:
+74.84%
1개월 성능:
+163.11%
6개월 성능:
+351.67%
1년 성능:
+371.39%
1일 변동 폭
$2.7005
$3.20
1주일 범위
$1.40
$3.20
52주 변동 폭
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
명칭
Novabay Pharmaceuticals Inc
전화
510-899-8800
주소
2000 Powell Street, Suite 1150, Emeryville, CA
NBY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
2.71 | 352.83M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-06 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 재확인 | Laidlaw | Buy |
| 2017-06-05 | 개시 | ROTH Capital | Buy |
| 2017-03-27 | 개시 | Laidlaw | Buy |
| 2017-02-06 | 개시 | Rodman & Renshaw | Buy |
| 2016-03-07 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-14 | 재확인 | Maxim Group | Buy |
| 2015-04-30 | 재개 | Maxim Group | Buy |
| 2013-03-06 | 개시 | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 개시 | Dawson James | Speculative Buy |
모두보기
Novabay Pharmaceuticals Inc 주식(NBY)의 최신 뉴스
What analysts say about NovaBay Pharmaceuticals Inc stockStock Price Divergence & Free Grow Wealth With Picks - earlytimes.in
Will Banas Finance Limited Benefit From Sector TailwindsMarket Timing Techniques & Free Rapid Portfolio Appreciation - earlytimes.in
Is Novabay Pharmaceuticals Inc (NBY) positioned for future growth? - Setenews
Is NovaBay Pharmaceuticals Inc a good long term investmentLong-Term Investment Plans & These 3 Stocks Could Change Your Portfolio - earlytimes.in
Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionInsider Selling & Weekly Top Gainers Trade List - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat growth indexesQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga
Is NovaBay Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Proven Capital Preservation Tips - Newser
Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosFed Meeting & Fast Gain Stock Trading Tips - Newser
Will NovaBay Pharmaceuticals Inc. stock recover faster than industryPortfolio Gains Summary & Safe Entry Momentum Stock Tips - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock split2025 Dividend Review & Safe Capital Investment Plans - Newser
Can NovaBay Pharmaceuticals Inc. stock double in coming years2025 Price Momentum & Growth Oriented Trade Recommendations - Newser
How NovaBay Pharmaceuticals Inc. stock benefits from strong dollar - BỘ NỘI VỤ
Will NovaBay Pharmaceuticals Inc. stock outperform tech sector in 2025Quarterly Growth Report & Breakout Confirmation Alerts - BỘ NỘI VỤ
[S-8] NovaBay Pharmaceuticals, Inc. Employee Benefit Plan Registration | NBY SEC FilingForm S-8 - Stock Titan
What Sparked KALA BIO's Nearly 38% Surge Overnight? - Benzinga
[S-3/A] NovaBay Pharmaceuticals, Inc. Amended Shelf Registration Statement | NBY SEC FilingForm S-3/A - Stock Titan
NovaBay Pharmaceuticals Inc. (NBY) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
How NovaBay Pharmaceuticals Inc. stock trades under stagflationJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat revenue estimatesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Will NovaBay Pharmaceuticals Inc. stock deliver compounding returns2025 Stock Rankings & Weekly Setup with ROI Potential - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock rise with strong economyWeekly Trade Summary & Safe Entry Momentum Tips - newser.com
How NovaBay Pharmaceuticals Inc. (B9P0) stock performs during market turbulence - newser.com
Can NovaBay Pharmaceuticals Inc. stock deliver sustainable ROEMarket Growth Report & High Conviction Investment Ideas - newser.com
Is NovaBay Pharmaceuticals Inc. stock a momentum leaderTrade Volume Report & Daily Oversold Stock Bounce Ideas - newser.com
Is NovaBay Pharmaceuticals Inc. stock suitable for passive index fundsBull Run & Verified Stock Trade Ideas - newser.com
How NovaBay Pharmaceuticals Inc. (B9P0) stock correlates with oil marketsNew Guidance & Verified Momentum Stock Watchlist - newser.com
Is NovaBay Pharmaceuticals Inc. stock at risk of policy regulationWeekly Trade Recap & Intraday High Probability Alerts - newser.com
How NovaBay Pharmaceuticals Inc. stock reacts to stronger dollar - newser.com
Why millennials buy NovaBay Pharmaceuticals Inc. stockMarket Weekly Review & Verified Swing Trading Watchlist - newser.com
Can NovaBay Pharmaceuticals Inc. stock beat analyst consensusEarnings Risk Summary & Real-Time Volume Analysis Alerts - newser.com
Novabay Pharmaceuticals Inc (NBY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.12%
자본화:
|
볼륨(24시간):